BMY icon

Bristol-Myers Squibb
BMY

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$45
9% downside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Andrew Baum
17 Nov ‘25 13 days ago